We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
-11.43%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$19.8B
AUM Growth
-$2.83B
Cap. Flow
+$212M
Cap. Flow %
1.07%
Top 10 Hldgs %
15.28%
Holding
2,395
New
108
Increased
1,282
Reduced
892
Closed
107

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$32.7M
2
CI icon
Cigna
CI
+$31.5M
3
LYB icon
LyondellBasell Industries
LYB
+$27.6M
4
VICI icon
VICI Properties
VICI
+$24.4M
5
CVS icon
CVS Health
CVS
+$21.2M

Sector Composition

Rank Sector Weight
1 Technology 17.58%
2 Financials 16.18%
3 Healthcare 14.54%
4 Consumer Discretionary 9.94%
5 Communication Services 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVX icon
26
Chevron
CVX
$382B
$108M 0.55%
994,367
-29,559
-3% -$3.42M
BA icon
27
Boeing
BA
$169B
$107M 0.54%
332,592
-11,411
-3% -$3.94M
CMCSA icon
28
Comcast
CMCSA
$87.3B
$107M 0.54%
3,129,439
+119,138
+4% +$4.35M
MCD icon
29
McDonald's
MCD
$193B
$105M 0.53%
591,877
+14,931
+3% +$2.65M
XOM icon
30
ExxonMobil
XOM
$650B
$99.1M 0.5%
1,453,267
-227,507
-14% -$17.8M
ACN icon
31
Accenture
ACN
$106B
$97.9M 0.49%
694,039
+68,454
+11% +$10.8M
T icon
32
AT&T
T
$164B
$95.5M 0.48%
4,431,832
-354,412
-7% -$8.25M
NVS icon
33
Novartis
NVS
$302B
$94.6M 0.48%
1,230,245
+153,892
+14% +$12M
AMGN icon
34
Amgen
AMGN
$209B
$94.5M 0.48%
485,592
+3,952
+0.8% +$771K
ABBV icon
35
AbbVie
ABBV
$465B
$94.4M 0.48%
1,024,365
+2,193
+0.2% +$193K
TMO icon
36
Thermo Fisher Scientific
TMO
$214B
$90M 0.45%
402,384
+5,177
+1% +$1.21M
TXN icon
37
Texas Instruments
TXN
$248B
$86.2M 0.43%
912,226
-6,175
-0.7% -$598K
MMM icon
38
3M
MMM
$91.8B
$85.1M 0.43%
534,378
-12,567
-2% -$2.09M
ORCL icon
39
Oracle
ORCL
$339B
$84.9M 0.43%
1,881,012
-89,472
-5% -$4.29M
ABT icon
40
Abbott
ABT
$187B
$82.3M 0.41%
1,137,285
+59,535
+6% +$4.18M
UNP icon
41
Union Pacific
UNP
$174B
$81.4M 0.41%
588,799
-6,918
-1% -$1.02M
ELV icon
42
Elevance Health
ELV
$81.5B
$77.9M 0.39%
296,725
+10,282
+4% +$2.83M
TSM icon
43
TSMC
TSM
$1.94T
$77.5M 0.39%
2,098,841
-179,357
-8% -$6.83M
HON icon
44
Honeywell
HON
$76.4B
$77.2M 0.39%
620,200
-40,519
-6% -$5.53M
ADBE icon
45
Adobe
ADBE
$105B
$77.2M 0.39%
341,048
+2,483
+0.7% +$599K
TJX icon
46
TJX Companies
TJX
$179B
$76.2M 0.38%
1,702,281
-89,791
-5% -$4.54M
WFC icon
47
Wells Fargo
WFC
$254B
$76.1M 0.38%
1,651,929
-360,099
-18% -$18.4M
NKE icon
48
Nike
NKE
$64.1B
$76.1M 0.38%
1,026,223
+26,361
+3% +$1.97M
CHL
49
DELISTED
China Mobile Limited
CHL
$74.8M 0.38%
1,557,842
-24,138
-2% -$1.16M
LLY icon
50
Eli Lilly
LLY
$1.08T
$72.3M 0.36%
624,479
+44,871
+8% +$5.01M

Similar funds

Aperio Group's Q4 2018 Portfolio in Review

As of Q4 2018, Aperio Group held 2,395 positions worth $19.8B, down 12% from $22.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Aperio Group's Q4 2018 filing shows 108 new, 1,282 increased, 892 reduced and 107 closed positions. Its largest new stake was Linde: 206,771 shares worth $32.3M. The largest sale was Aetna Inc, an estimated $67.4M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q4 2018 buy was Linde: 206,771 shares worth $32.3M.
  • Aperio Group added most to Cigna in Q4 2018, an estimated $31.5M increase.
  • Aperio Group's biggest Q4 2018 reduction was Apple, cutting an estimated $28.3M.
  • Aperio Group fully exited Aetna Inc in Q4 2018, selling an estimated $67.4M.
  • Aperio Group's ten largest holdings make up 15% of its $19.8B portfolio in Q4 2018.
  • Aperio Group opened 108 new positions and closed 107 in Q4 2018.
  • Aperio Group's portfolio value fell 12% quarter-over-quarter to $19.8B.

Based on Aperio Group's 13F filing for Q4 2018, filed 14 Feb 2019.